Dividend Dud #1 - Pfizer (PFE)
Drugmaker Pfizer (PFE) is fairly popular among dividend stock investors, considering its nearly 5% yield and a market cap of about $116 billion. Sounds like a conservative stock that's sure to protect your portfolio, right?Well think again. Pfizer shares are off about -20% this year as costs of last year’s Wyeth merger continue to weigh on its bottom line. On top of that, looming patent expirations on blockbusters like Viagra and Lipitor cast doubt on the long-term futures of PFE stock. Yes, the company just paid an 18 cent dividend in May, but that’s small recompense for the loss in share value -- and the threat of continued declines are enough to give investors pause.
Dividend Dud #1 - Pfizer (PFE)
No comments:
Post a Comment